CompletedNot Applicable

Effectiveness of Low-intensity Laser on Pain in Patients With Supraspinatus Tendinopathy.

Spain40 participantsStarted 2023-09-12

Plain-language summary

Tendinopathy is an inflammatory process that occurs in and around the tendon when both are affected by a certain injury. In the case of the supraspinatus muscle it is one of the most frequent causes of shoulder pain. To test the efficacy of laser treatment in reducing shoulder pain caused by supraspinatus muscle tendinopathy. A randomized controlled clinical trial (RCT) was carried out in which a physiotherapy intervention was performed using therapeutic laser for three months, to observe the influence on the pain generated by supraspinatus muscle tendinopathy in the shoulder.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Score of 3 or higher on the VAS scale for the shoulder. * Adequate cognitive ability for comprehension. * Rotator cuff tendinopathy confirmed by ultrasound at the study center, either due to tendon inflammation, presence of hypoechoic areas, calcification, fibrillar disorganization, and/or neovascularization in the supraspinatus muscle. * Pain in the proximal lateral part of the arm that worsens with abduction. Exclusion Criteria: * Contraindications specific to laser treatment (e.g., tumors, presence of pacemaker or defibrillator, pregnancy, etc.). * History of glenohumeral fracture and rheumatoid arthritis. * Rheumatic, neurological, or structural polymyalgia affecting the joint. * Previous surgeries. * Pregnant or breastfeeding women. * Taking anticoagulants or antiplatelet agents. * Diabetes mellitus. * Cardiac dysfunction. * Infiltrative and/or rehabilitative treatment in the two months prior to recruitment. * Pre-existing conditions associated with pain in the upper extremities. Difficulties with follow-up. * Depression. * Treatment with another intervention; during the study, they will not be able to undergo it.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

intensity of pain.

Timeframe: 3 months

Trial details

NCT IDNCT07261449

SponsorUniversidad Pontificia de Salamanca

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-24

View on ClinicalTrials.gov More Tendinopathy trials